Neuralbase AI Ltd. Files S-1/A Amendment

TL;DR

Neuralbase AI Ltd. (fka Viratech) filed an S-1/A amendment on 2/12/25. Details on preferred stock deals. Check it out.

AI Summary

Neuralbase AI Ltd. filed an S-1/A amendment on February 12, 2025, detailing its business and financial status. The company, formerly known as Viratech Corp., is involved in motion picture and video tape production and is incorporated in Nevada. The filing includes information on preferred stock transactions and agreements, such as an Asset Purchase Agreement dated March 8, 2023, and an Unwind Agreement dated May 16, 2024.

Why It Matters

This S-1/A filing provides updated information for investors and the public regarding Neuralbase AI Ltd.'s corporate structure, recent agreements, and financial disclosures, which can influence investment decisions.

Risk Assessment

Risk Level: medium — The filing is an amendment to an S-1, indicating ongoing efforts to go public or provide updated disclosures, which inherently carries risks associated with early-stage or evolving companies.

Key Numbers

• $480.0M — Filing Value (Part of the financial details in the S-1/A filing.)
• $2.5B — Filing Value (Part of the financial details in the S-1/A filing.)
• $10.0M — Filing Value (Part of the financial details in the S-1/A filing.)
• $3.5M — Filing Value (Part of the financial details in the S-1/A filing.)
• $9.0M — Filing Value (Part of the financial details in the S-1/A filing.)

Key Players & Entities

• NEURALBASE AI LTD. (company) — Filer
• Viratech Corp. (company) — Former company name
• Imperia Entertainment, Inc. (company) — Former company name
• Soleil Film, Inc. (company) — Former company name
• 20250212 (date) — Filing date
• 0001130781 (company) — Central Index Key
• 7812 (industry_code) — Standard Industrial Classification
• 727-314-3717 (phone_number) — Business phone
• 333-284623 (filing_number) — SEC File Number
• 25614355 (film_number) — Film Number

FAQ

Key Financial Figures

• $0.0001 — 0 shares of our common stock, par value $0.0001 (" Common Stock ") at a fixed price of
• $0.01 — (" Common Stock ") at a fixed price of $0.01 per share for the duration of this offe
• $400,000 — pany are sold, the Company will receive $400,000 in net proceeds. Assuming 30,000,000 sh
• $300,000 — pany are sold, the Company will receive $300,000 in net proceeds. Assuming 20,000,000 sh
• $200,000 — pany are sold, the Company will receive $200,000 in net proceeds. Assuming 10,000,000 sh
• $100,000 — pany are sold, the Company will receive $100,000 in net proceeds. There is no minimum am
• $400,000 M — g Summary: Total Amount to be Raised: $400,000 Minimum Amount Needed for next 12 months
• $50,000 — We anticipate that we need a minimum of $50,000 dollars to continue operations for the
• $300,000.00 — ng key areas: 1. Product Development: $300,000.00 Continued development and refinement
• $75,000.00 M — sary software/hardware 2. Marketing: $75,000.00 Marketing campaigns (digital, social medi
• $25,000.00 M — ts 3. Operations and Infrastructure: $25,000.00 Milestones: Over the 12-month period, the

Filing Documents

• vira_s1a.htm (S-1/A) — 1292KB
• vira_ex51.htm (EX-5.1) — 12KB
• vira_ex231.htm (EX-23.1) — 2KB
• vira_ex51img1.jpg (GRAPHIC) — 9KB
• vira_ex51img2.jpg (GRAPHIC) — 3KB
• 0001477932-25-000901.txt ( ) — 3635KB
• vira-20240930.xsd (EX-101.SCH) — 31KB
• vira-20240930_lab.xml (EX-101.LAB) — 169KB
• vira-20240930_cal.xml (EX-101.CAL) — 34KB
• vira-20240930_pre.xml (EX-101.PRE) — 140KB
• vira-20240930_def.xml (EX-101.DEF) — 90KB
• vira_s1a_htm.xml (XML) — 373KB

Risk Factors

Risk Factors 10 Special Note Regarding Forward-Looking Statements 19 Industry And Other Data 20

Use Of Proceeds

Use Of Proceeds 21 Dividend Policy 21

Management's Discussion And Analysis Of Financial Condition And Results Of Operations

Management's Discussion And Analysis Of Financial Condition And Results Of Operations 23

Business

Business 26 Management 43 Executive And Director Compensation 43 Certain Relationships And Related Party Transactions 44 Principal Stockholders 44

Description Of Capital Stock

Description Of Capital Stock 45 Shares Eligible For Future Sale 47 Material U.S. Federal Income Tax Consequences To Non-U.S. Holders Of Our Common Stock 48 Legal Matters 52 Experts 52 Where You Can Find More Information 52 Index To Financial Statements 53 The Company has not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of Common Stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our Common Stock. Our business, financial condition, results of operations and prospects may have changed since that date. For investors outside the United States : We have taken no actions that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of Common Stock and the distribution of this prospectus outside the United States. 1 Table of Contents PROSPECTUS SUMMARY This summary highlights certain information appearing elsewhere in this prospectus. Because it is only a summary, it does not contain all of the information that you should consider before investing in shares of our common stock and it is qualified in its entirety by, and should be read in conjunction with, the more detailed in

View Full Filing

View this S-1/A filing on SEC EDGAR